Event Abstract

Study of some Biological effects of the root ethanolic extract of Rubia peregrina

  • 1 Laboratory of Pharmacology, Neurobiology and behaviour, Faculty of Science, Morocco
  • 2 Laboratory of Chemical of Natural substances and Heterocycles, Faculty of Science, Morocco

Rubia peregrina is a member of the family (Rubiaceae) known in Morocco as "Foua" is used in folk medicine particularly for the treatment of anaemia as well as the illness of liver and hypotensive diseases.

Aim of study: the objectives of this study were to investigate the analgesic and anti-inflammatory effects of the root ethanolic extract of Rubia peregrine (R.P.)

Materials and methods: the analgesic effects of (R.P.) were evaluated with three models: acetic acid induced writhing response, formalin test and hot plate test in mice and the inflammation induced by xylene in the mice ear oedema model was adopted to study the anti-inflammatory activity of (R.P.).

Results: oral administration of roots ethanolic extract dependently reduced the behavioural response in formalin and writhing test and inhibited both phases of pain. It also increased latencies in the thermal stimuli models. Ethanolic extract orally administered significantly reduced the xylene induced ear oedema.

Conclusion: The results suggested that Rubia peregrina possessed the analgesic and anti-inflammatory activities.

Keywords: Inflammation, Mice, Nociception, Rubia peregrina

Conference: 3rd Mediterranean Conference of Neuroscience , Alexandria, Egypt, 13 Dec - 16 Dec, 2009.

Presentation Type: Poster Presentation

Citation: Chaib S, Mountassir M, Bensalah A, Ouachrif A, Khalki H, Regragui A, Loughzail M, Benharref A and Chait A (2009). Study of some Biological effects of the root ethanolic extract of Rubia peregrina. Front. Neurosci. Conference Abstract: 3rd Mediterranean Conference of Neuroscience . doi: 10.3389/conf.neuro.01.2009.16.174

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 26 Nov 2009; Published Online: 26 Nov 2009.

* Correspondence: Samira Chaib, Laboratory of Pharmacology, Neurobiology and behaviour, Faculty of Science, Marrakesh, Morocco, chaib.samira@yahoo.fr